Editorial
“Act like a man of thought, think like a man of action.” Thomas Mann was who gave this sentence, which in turn could be applied to the edition of Bioagora 2011.
Create, share and apply the knowledge has been the leitmotiv of Bioagora, the same as in the book entitled Knowledge in action, by Thomas Davenport and Laurence Prusak, about the management of knowledge and the need of companies to share it and put it into practice on a worldwide scale.
In a globalized world like today, old tools and solutions are not useful anymore; we cannot apply the same mental patterns as we have up ![]()
2011 was an intense year for Spanish Science. In the middle of a wave of budget cuts and adjustments, Catalonia continues to get good results in the Impact Factor, in the implementation of projects, in receiving grants and enlarging the infrastructure. Currently Catalonia collects 29% of the European funds that go to the whole state to boost R & D, i.e. 2% of the total European subsidies. We offer hereunder an extrapolation of the most important data that form the Catalan biotech scene of
[+ photos]
Manel Esteller, director of the Epigenetics and Cancer Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor has been awarded with the International Research Award of Fundación Dexeus, Women’s Health in its eighth edition.
The award honors a person whose career and continuing line of research constitutes a significant contribution in the field of Health Sciences, especially regarding women. In the case of Manel Esteller, the ![]()
The European Research Council (ERC) has awarded with a Starting Grant for scientific excellence Oriol Casanovas, researcher at IDIBELL and at the Catalan Institute of Oncology for the project 'Mechanisms and Targeting Stromal Tumor Invasion Contribution tone and Metastasis'. The funded project, called Stromalign, focuses on the study of tumor stroma as a possible major factor in the malignancy after anti-angiogenic therapies. The grant is 1.5 billion over five years. The funded project, ![]()
A new spin-off company created by IBEC and the UPC will focus on the manufacture and marketing of surgical systems.
Rob Surgical Systems Inc., a technology company driven by IBEC group leader Alicia Casals and senior researcher Manuel Frigola, as well as Josep Amat of the Automatic Control and Computer Engineering Department of the UPC, was approved by the university’s governing council on Friday.
The company will manufacture the systems that IBEC’s Robotics group has been ![]()